1-20 of 158
Yi Lin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results

Clinical Trials & Observations
Bijal D Shah, Michael R. Bishop, Olalekan O Oluwole, Aaron C Logan, Maria R. Baer, William B Donnellan, Kristen M O'Dwyer, Houston Holmes, Martha L. Arellano, Armin Ghobadi, John M. Pagel, Yi Lin, Ryan D Cassaday, Jae Park, Mehrdad Abedi, Januario Castro, Daniel J DeAngelo, Adriana K. Malone, Raya Mawad, Gary Schiller, John Michael Rossi, Adrian Bot, Tong Shen, Lovely Goyal, Rajul K. Jain, Remus Vezan, William George Wierda
Journal: Blood
Blood blood.2020009098.
DOI: https://doi.org/10.1182/blood.2020009098
Published: 2021
Includes: Supplemental data
Journal Articles

Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy

Clinical Trials & Observations
Jay Y. Spiegel, Saurabh Dahiya, Michael D. Jain, John Tamaresis, Loretta J. Nastoupil, Miriam T. Jacobs, Armin Ghobadi, Yi Lin, Matthew Lunning, Lazaros Lekakis, Patrick Reagan, Olalekan Oluwole, Joseph McGuirk, Abhinav Deol, Andre Goy, Khoan Vu, Charalambos Andreadis, Javier Munoz, N. Nora Bennani, Julie M. Vose, Kathleen A. Dorritie, Sattva S. Neelapu, Frederick L. Locke, Aaron P. Rapoport, Brian T. Hill, David B. Miklos
Journal: Blood
Blood (2021) 137 (13): 1832–1835.
DOI: https://doi.org/10.1182/blood.2020006245
Published: 2021
Includes: Supplemental data
Journal Articles

Lines of Therapy before Autologous Stem Cell Transplant (ASCT) and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin's Lymphoma (NHL)

Arushi Khurana, MBBS, Matthew A Hathcock, Thomas M. Habermann, MD, Abdullah S. Al Saleh, MBBS, Sangeetha Gandhi, MBBS, Tuan A Truong, Nabila Bennani, MD, Jonas Paludo, MD, Jose C Villasboas, MD, Stephen M. Ansell, MD PhD, David J. Inwards, MD, Luis F. Porrata, MD, Patrick B. Johnston, Ivana Micallef, MD, Yi Lin, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
DOI: https://doi.org/10.1182/blood-2020-142511
Published: 2020
Journal Articles

Outcomes of Patients (Pts) in ZUMA-9, a Multicenter, Open-Label Study of Axicabtagene Ciloleucel (Axi-Cel) in Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL) for Expanded Access and Commercial Out-of-Specification (OOS) Product

Caron A. Jacobson, MD, Frederick L. Locke, MD, David B. Miklos, MD PhD, Julie M. Vose, MD MBA, Yi Lin, MD PhD, Lihua E Budde, MD PhD, David G. Maloney, MD PhD, Samantha Jaglowski, MD MPH, Peter A. Riedell, MD, Lazaros J. Lekakis, MD, Miguel-Angel Perales, MD, Jenny J. Kim, MD MS, Jun Kawashima, MD, Yin Yang, MS, John M. Rossi, MS, Lovely Goyal, PhD, Sattva S. Neelapu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
DOI: https://doi.org/10.1182/blood-2020-136136
Published: 2020
Journal Articles

MASS-FIX for the Diagnosis of Plasma Cell Disorders: A Single Institution Experience of 4118 Patients

Patrick Mellors, Surendra Dasari, PhD, Mindy Kohlhagen, Bonnie Kaye Arendt, Morie A. Gertz, MD, Shaji K. Kumar, MD, Francis K. Buadi, MB, CHB, Maria Alice V. Willrich, PhD, John A. Lust, MD PhD, Prashant Kapoor, MD, Martha Q. Lacy, MD, David Dingli, MD PhD, Yi L. Hwa, NP, Amie Fonder, PA-C, MS, Miriam A. Hobbs, APRN, CNP, DNP, Suzanne R. Hayman, MD, Taxiarchis Kourelis, MD, Rahma M Warsame, MD, Eli Muchtar, MD, Nelson Leung, MD, Ronald S. Go, MD, Yi Lin, MD PhD, Wilson I Gonsalves, MD, Mustaqeem Siddiqui, MD, Robert A. Kyle, MD, S. Vincent Rajkumar, MD, David L. Murray, MDPhD, Angela Dispenzieri, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 48–49.
DOI: https://doi.org/10.1182/blood-2020-138829
Published: 2020
Journal Articles

The Prognostic Significance of Acquired 1q22 Gain in Multiple Myeloma

Hadiyah Y. Audil, MD, Joselle Cook, MBBS, Patricia Greipp, DO, Prashant Kapoor, MD, Linda B Baughn, PhD, Angela Dispenzieri, MD, Morie A Gertz, MD, Francis K. Buadi, MB, CHB, Martha Q. Lacy, MD, David Dingli, MD PhD, Amie Fonder, PA-C, MS, Suzanne R. Hayman, MD, Miriam A. Hobbs, APRN, CNP, DNP, Eli Muchtar, MD, Mustaqeem A. Siddiqui, MDMBA, Wilson I Gonsalves, MD, Yi L. Hwa, NP, Nelson Leung, MD, Ronald S. Go, MD, Yi Lin, MD PhD, Taxiarchis Kourelis, MD, Rahma M Warsame, MD, John A. Lust, MD PhD, Robert A. Kyle, MD, Rhett P. Ketterling, MD, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
DOI: https://doi.org/10.1182/blood-2020-139093
Published: 2020
Journal Articles

Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease--a Single Institution Observation in China

Baiyan Wang, MD PhD, Jie Liu, MD, Wan-Hong Zhao, MD PhD, Yin-Xia Chen, MD, Xing-Mei Cao, MD, Yun Yang, MD, Yi-Lin Zhang, MD, Fang-Xia Wang, MD PhD, Peng-Yu Zhang, MD PhD, Bo Lei, MD, Liu-Fang Gu, MD PhD, Jian-Li Wang, MD PhD, Frank Xiao-Hu Fan, MD PhD, Wang-Gang Zhang, MD PhD, Ai-Li He, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6.
DOI: https://doi.org/10.1182/blood-2020-140243
Published: 2020
Journal Articles

Phase I Trial of Systemic Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon Beta, in Patients with Relapsed or Refractory Multiple Myeloma (MM), Acute Myeloid Leukemia (AML), and T-Cell Neoplasms (TCL)

Joselle Cook, MBBS, Kah-Whye Peng, PhD, Brenda F Ginos, B.A., Amylou C. Dueck, PhD, Marissa Giers, BSN, RN, Nandakumar Packiriswamy, PhD DVM, Beth Brunton, PhD, Mrinal M. Patnaik, MDMBBS, Thomas E. Witzig, MD, Francis K. Buadi, MB, CHB, Angela Dispenzieri, MD, Morie A Gertz, MD, Ronald S. Go, MD, Suzanne R. Hayman, MD, John A. Lust, MD PhD, David Dingli, MD PhD, S. Vincent Rajkumar, MD, Nelson Leung, MD, Rahma M Warsame, MD, Wilson I Gonsalves, MD, Taxiarchis Kourelis, MD, Eli Muchtar, MD, P. Leif Bergsagel, MD, Stephen Broski, MD, Prashant Kapoor, MD, Robert A. Kyle, MD, Mustaqeem A. Siddiqui, MDMBA, Amie Fonder, PA-C, MS, Miriam A. Hobbs, APRN, CNP, DNP, Yi L. Hwa, NP, Yi Lin, MD PhD, Shaji K. Kumar, MD, Stephen J. Russell, MD PhD, Martha Q. Lacy, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 7–8.
DOI: https://doi.org/10.1182/blood-2020-140853
Published: 2020
Journal Articles

Continued Improvement in Survival of Patients with Newly Diagnosed Multiple Myeloma (MM)

Bharat Nandakumar, Prashant Kapoor, MD, Moritz Binder, MDMPH, Francis K. Buadi, MB, CHB, Martha Q. Lacy, MD, Morie A. Gertz, MD, Angela Dispenzieri, MD, David Dingli, MD PhD, Yi L. Hwa, NP, Amie Fonder, PA-C, MS, Miriam A. Hobbs, APRN, CNP, DNP, Suzanne R. Hayman, MD, John A. Lust, MD PhD, Stephen J. Russell, MD PhD, Nelson Leung, MD, Ronald S. Go, MD, Yi Lin, MD PhD, Wilson I Gonsalves, MD, Taxiarchis Kourelis, MD, Rahma M Warsame, MD, Mustaqeem A. Siddiqui, MDMBA, Robert A. Kyle, MD, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
DOI: https://doi.org/10.1182/blood-2020-140388
Published: 2020
Journal Articles

Health-Related Quality of Life in the Cartitude-1 Study of Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma

Thomas Martin, III, MD, Yi Lin, MD PhD, Mounzer Agha, MD, Adam D. Cohen, MD, Myo Htut, MD, A. Keith Stewart, MBChB, Parameswaran Hari, MD MRCP, Jesus G. Berdeja, MD, Deepu Madduri, MD, Saad Z. Usmani, MDMBBS,MBA, Tzu-Min Yeh, Alicia J. Allred, PhD, Yunsi Olyslager, MSc, Arnob Banerjee, MD, Jenna D. Goldberg, MD, Jordan M. Schecter, MD, Carolyn C. Jackson, MD MPH, William Deraedt, MSc, Katharine S. Gries, PhD PharmD, John Fastenau, RPh, MPH, PhD, Xiaoling Wu, PhD, Marlene J. Carrasco, MD PhD MPH, Muhammad Akram, MD, Farah Hossain, PharmD, Andrzej Jakubowiak, MD PhD, Sundar Jagannath, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 41–42.
DOI: https://doi.org/10.1182/blood-2020-136368
Published: 2020
Journal Articles

Prognostic Restaging after Treatment Initiation in Patients with AL Amyloidosis

Nadine Abdallah, MD, Angela Dispenzieri, MD, Eli Muchtar, MD, Francis K. Buadi, MB, CHB, Prashant Kapoor, MD, Martha Q. Lacy, MD, Yi L. Hwa, NP, Amie Fonder, PA-C, MS, Miriam A. Hobbs, APRN, CNP, DNP, Suzanne R. Hayman, MD, Nelson Leung, MD, David Dingli, MD PhD, John A. Lust, MD PhD, Ronald S. Go, MD, Yi Lin, MD PhD, Wilson I Gonsalves, MD, Taxiarchis Kourelis, MD, Rahma M Warsame, MD, Robert A. Kyle, MD, S. Vincent Rajkumar, MD, Morie A Gertz, MD, Shaji K. Kumar, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
DOI: https://doi.org/10.1182/blood-2020-139356
Published: 2020
Journal Articles

Characterization of Cytokine Release Syndrome in the KarMMa Study of Idecabtagene Vicleucel (ide-cel, bb2121) for Relapsed and Refractory Multiple Myeloma

Ankit Kansagra, MD, Yi Lin, MD PhD, Jesus G. Berdeja, MD, Nina Shah, MD, Albert Oriol, MD, Ibrahim Yakoub-Agha, Hermann Einsele, MD, Alessandro Rambaldi, MD, Anna Truppel-Hartmann, MD, Everton Rowe, PhD, Julie Wang, PharmD, PhD, Amit Agarwal, MD PhD, Timothy B. Campbell, MD PhD, Sagar Lonial, MD FACP
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–27.
DOI: https://doi.org/10.1182/blood-2020-134383
Published: 2020
Journal Articles

Efficacy and Safety of Idecabtagene Vicleucel (ide-cel, bb2121) in Elderly Patients with Relapsed and Refractory Multiple Myeloma: KarMMa Subgroup Analysis

Jesus G. Berdeja, MD, Noopur S. Raje, MD, David S. Siegel, MD PhD, Yi Lin, MD PhD, Larry D. Anderson, Jr., MD PhD, Paula Rodriguez-Otero, MD PhD, Salomon Manier, MD PhD, Hermann Einsele, MD, Michele Cavo, Anna Truppel-Hartmann, MD, Everton Rowe, PhD, Jill Sanford, MS, Julie Wang, PharmD, PhD, Timothy B. Campbell, MD PhD, Sundar Jagannath, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
DOI: https://doi.org/10.1182/blood-2020-134322
Published: 2020
Journal Articles

The Utility of Granulocyte Colony Stimulating Factor in Patients Receiving Chimeric Antigen Receptor T-Cell Therapy with Axicabtagene Ciloleucel

Jason N Barreto, PharmD, Corina J Doleski, PharmD, Justin R Hayne, PA-C, Matthew A Hathcock, Tuan A Truong, Stephen M. Ansell, MD PhD, Nabila Bennani, MD, Jonas Paludo, MD, Jose C Villasboas, MD, Yi Lin, MD PhD, Patrick B. Johnston
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–25.
DOI: https://doi.org/10.1182/blood-2020-142150
Published: 2020
Journal Articles

Unmet Needs in AL Amyloidosis: Outcomes in the Modern Era Among the Highest Risk, Newly Diagnosed AL Amyloidosis Patients

Angela Dispenzieri, MD, Shaji K. Kumar, MD, Francis K. Buadi, MB, CHB, Martha Q. Lacy, MD, David Dingli, MD PhD, Yi L. Hwa, NP, Amie Fonder, PA-C, MS, Miriam A. Hobbs, APRN, CNP, DNP, Suzanne R. Hayman, MD, Taxiarchis Kourelis, MD, Rahma M Warsame, MD, Eli Muchtar, MD, Nelson Leung, MD, Prashant Kapoor, MD, Martha Grogan, MD, Yi Lin, MD PhD, Ronald S. Go, MD, Wilson I Gonsalves, MD, Mustaqeem A. Siddiqui, MDMBA, Robert A. Kyle, MD, John A. Lust, MD PhD, S. Vincent Rajkumar, MD, Morie A Gertz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
DOI: https://doi.org/10.1182/blood-2020-141604
Published: 2020
Journal Articles

Sequential Comparison of Conventional Serum Immunofixation (IFE) to Mass Spectrometry-Based Assessment (MASS FIX) in Patients with Multiple Myeloma (MM)

Bharat Nandakumar, David L. Murray, MDPhD, Angela Dispenzieri, MD, Prashant Kapoor, MD, Francis K. Buadi, MB, CHB, Martha Q. Lacy, MD, Morie A. Gertz, MD, David Dingli, MD PhD, Yi L. Hwa, NP, Amie Fonder, PA-C, MS, Miriam A. Hobbs, APRN, CNP, DNP, Suzanne R. Hayman, MD, John A. Lust, MD PhD, Nelson Leung, MD, Ronald S. Go, MD, Yi Lin, MD PhD, Wilson I Gonsalves, MD, Taxiarchis Kourelis, MD, Rahma M Warsame, MD, Mustaqeem A. Siddiqui, MDMBA, Robert A. Kyle, MD, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
DOI: https://doi.org/10.1182/blood-2020-141342
Published: 2020
Journal Articles

Prognostic Impact of PET Findings Post-Transplant in Multiple Myeloma

Marcella Tschautscher, MD, David Dingli, MD PhD, Francis K. Buadi, MB, CHB, Martha Q. Lacy, MD, Morie A Gertz, MD, Angela Dispenzieri, MD, Prashant Kapoor, MD, Yi L. Hwa, NP, Amie Fonder, PA-C, MS, Miriam A. Hobbs, APRN, CNP, DNP, Suzanne R. Hayman, MD, John A. Lust, MD PhD, Nelson Leung, MD, Ronald S. Go, MD, Yi Lin, MD PhD, Wilson I Gonsalves, MD, Taxiarchis Kourelis, MD, Rahma M Warsame, MD, Robert A. Kyle, MD, Stephen Broski, MD, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
DOI: https://doi.org/10.1182/blood-2020-136832
Published: 2020
Journal Articles

Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma Treated with Ciltacabtagene Autoleucel in the Phase 1b/2 CARTITUDE-1 Study

Yi Lin, MD PhD, Thomas Martin, III, MD, Adam D. Cohen, MD, Andrzej Jakubowiak, MD PhD, Jagoda Jasielec, MD, Saad Z. Usmani, MDMBBS,MBA, Deepu Madduri, MD, Mounzer Agha, MD, A. Keith Stewart, MBChB, Indrajeet Singh, PhD, Enrique Zudaire, PhD, Tzu-Min Yeh, Alicia J. Allred, PhD, Yunsi Olyslager, MSc, Arnob Banerjee, MD, Jenna D. Goldberg, MD, Jordan M. Schecter, MD, Carolyn C. Jackson, MD MPH, William Deraedt, MSc, Dong Geng, PhD, Xiaoling Wu, PhD, Marlene J. Carrasco, MD PhD MPH, Muhammad Akram, MD, Farah Hossain, PharmD, Vickie Wang, PhD, Jesus G. Berdeja, MD, Sundar Jagannath, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
DOI: https://doi.org/10.1182/blood-2020-136360
Published: 2020
Journal Articles

Long-Term Survival and Gradual Recovery of B Cells in Patients with Refractory Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel (Axi-Cel)

Caron Jacobson, MD MMSc, Frederick L. Locke, MD, Armin Ghobadi, MD, David B. Miklos, MD PhD, Lazaros J. Lekakis, MD, Olalekan O. Oluwole, MBBS, MPH, Yi Lin, MD PhD, Ira Braunschweig, MD, Brian T. Hill, MD, John M. Timmerman, MD, Abhinav Deol, MD, Patrick M. Reagan, MD, Patrick J. Stiff, MD, Ian W. Flinn, MD PhD, Umar Farooq, MD, Andre H. Goy, MD, Peter A. McSweeney, MD, Javier Munoz, MD, Tanya Siddiqi, MD, John M. Rossi, MS, Adrian Bot, MD PhD, Lianqing Zheng, PhD, Remus Vezan, MD PhD, Zahid Bashir, MBBS, Jenny J. Kim, MD MS, Rong Chu, PhD, Sattva S. Neelapu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–42.
DOI: https://doi.org/10.1182/blood-2020-134362
Published: 2020
Journal Articles

Response to Bridging Therapy (BT) before CAR-T Cell Infusion Predicts Outcomes for Relapsed/Refractory (R/R) Aggressive B-Cell Non-Hodgkin Lymphoma (NHL)

Arushi Khurana, MBBS, Abdullah S. Al Saleh, MBBS, Sangeetha Gandhi, MBBS, Tuan A Truong, Nabila Bennani, MD, Jonas Paludo, MD, Jose C Villasboas, MD, Patrick B. Johnston, Stephen M. Ansell, MD PhD, Yi Lin, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30.
DOI: https://doi.org/10.1182/blood-2020-141058
Published: 2020